These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

118 related articles for article (PubMed ID: 10614995)

  • 1. FR190997, a novel bradykinin B2 agonist, expresses longer action than bradykinin in paw edema formation and hypotensive response.
    Ueno A; Naraba H; Kojima F; Morita E; Oh-ishi S
    Immunopharmacology; 1999 Dec; 45(1-3):89-93. PubMed ID: 10614995
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Mouse paw edema induced by a novel bradykinin agonist and its inhibition by B2-antagonists.
    Ueno A; Naraba H; Oh-ishi S
    Jpn J Pharmacol; 1998 Sep; 78(1):109-11. PubMed ID: 9804073
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Proinflammatory characteristics of a nonpeptide bradykinin mimic, FR190997, in vivo.
    Hayashi I; Ishihara K; Kumagai Y; Majima M
    Br J Pharmacol; 2001 Aug; 133(8):1296-306. PubMed ID: 11498515
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Effects of FR173657, a non-peptide B2 antagonist, on kinin-induced hypotension, visceral and peripheral oedema formation and bronchoconstriction.
    Griesbacher T; Legat FJ
    Br J Pharmacol; 1997 Mar; 120(5):933-9. PubMed ID: 9138701
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Peptide and non-peptide bradykinin B2 receptor agonists and antagonists: a reappraisal of their pharmacology in the guinea-pig ileum.
    Meini S; Patacchini R; Lecci A; Quartara L; Maggi CA
    Eur J Pharmacol; 2000 Dec; 409(2):185-94. PubMed ID: 11104833
    [TBL] [Abstract][Full Text] [Related]  

  • 6. A nonpeptide mimic of bradykinin blunts the development of hypertension in young spontaneously hypertensive rats.
    Majima M; Hayashi I; Inamura N; Fujita T; Ogino M
    Hypertension; 2000 Jan; 35(1 Pt 2):437-42. PubMed ID: 10642338
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Systemic treatment with Mycobacterium bovis bacillus Calmette-Guérin (BCG) potentiates kinin B1 receptor agonist-induced nociception and oedema formation in the formalin test in mice.
    de Campos RO; Henriques MG; Calixto JB
    Neuropeptides; 1998 Oct; 32(5):393-403. PubMed ID: 9844998
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Pharmacological characterization of a nonpeptide bradykinin B2 receptor antagonist, FR165649, and agonist, FR190997.
    Asano M; Hatori C; Sawai H; Johki S; Inamura N; Kayakiri H; Satoh S; Abe Y; Inoue T; Sawada Y; Mizutani T; Oku T; Nakahara K
    Br J Pharmacol; 1998 Jun; 124(3):441-6. PubMed ID: 9647466
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Antinociceptive profile of the pseudopeptide B2 bradykinin receptor antagonist NPC 18688 in mice.
    Corrêa CR; Kyle DJ; Chakraverty S; Calixto JB
    Br J Pharmacol; 1996 Feb; 117(3):552-558. PubMed ID: 8821548
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Modulation of kinin B1 but not B2 receptors-mediated rat paw edema by IL-1beta and TNFalpha.
    Campos MM; Souza GE; Calixto JB
    Peptides; 1998; 19(7):1269-76. PubMed ID: 9786178
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The role of B1 and B2 kinin receptors in oedema formation after long-term treatment with Mycobacterium bovis bacillus Calmette-Guérin (BCG).
    Campos MM; Henriques MG; Calixto JB
    Br J Pharmacol; 1997 Feb; 120(3):502-8. PubMed ID: 9031756
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Characterization of non-peptide bradykinin B2 receptor agonist (FR 190997) and antagonist (FR 173657).
    Gobeil F; Montagne M; Inamura N; Regoli D
    Immunopharmacology; 1999 Sep; 43(2-3):179-85. PubMed ID: 10596851
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Nonpeptide mimic of bradykinin with long-acting properties at the bradykinin B2 receptor.
    Aramori I; Zenkoh J; Morikawa N; Asano M; Hatori C; Sawai H; Kayakiri H; Satoh S; Inoue T; Abe Y; Sawada Y; Mizutani T; Inamura N; Nakahara K; Kojo H; Oku T; Notsu Y
    Mol Pharmacol; 1997 Jul; 52(1):16-20. PubMed ID: 9224807
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Involvement of B1 and B2 receptors in bradykinin-induced rat paw oedema.
    Campos MM; Calixto JB
    Br J Pharmacol; 1995 Mar; 114(5):1005-13. PubMed ID: 7780633
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Anion secretory effects of a non-peptide mimic of bradykinin (FR190997) on mouse colon epithelium.
    Cuthbert AW
    Immunopharmacology; 1999 Dec; 45(1-3):191-8. PubMed ID: 10615011
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Mediation by bradykinin of rat paw oedema induced by collagenase from Clostridium histolyticum.
    Legat FJ; Griesbacher T; Lembeck F
    Br J Pharmacol; 1994 Jun; 112(2):453-60. PubMed ID: 7915609
    [TBL] [Abstract][Full Text] [Related]  

  • 17. 5-hydroxytryptamine release from skin mast cells in vivo induced by peptide but not by nonpeptide ligands for bradykinin receptors.
    Griesbacher T; Rainer I
    Immunopharmacology; 1999 Sep; 43(2-3):195-201. PubMed ID: 10596853
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Upregulation of B1 receptor mediating des-Arg9-BK-induced rat paw oedema by systemic treatment with bacterial endotoxin.
    Campos MM; Souza GE; Calixto JB
    Br J Pharmacol; 1996 Mar; 117(5):793-8. PubMed ID: 8851492
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The N-terminal of icatibant and bradykinin interact with the same Asp residues in the human B2 receptor.
    Bellucci F; Meini S; Cucchi P; Catalani C; Giuliani S; Zappitelli S; Rotondaro L; Quartara L; Giolitti A; Maggi CA
    Eur J Pharmacol; 2004 May; 491(2-3):121-5. PubMed ID: 15140628
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Effects of an orally active non-peptide bradykinin B2 receptor antagonist, FR173657, on plasma exudation in rat carrageenin-induced pleurisy.
    Majima M; Kawashima N; Hiroshi I; Katori M
    Br J Pharmacol; 1997 Jun; 121(4):723-30. PubMed ID: 9208140
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.